AURKA and glioblastoma: VX680 (tozasertib), a pan aurora kinase inhibitor, and MLN8237 (alisertib), a highly selective AURKA inhibitor, have been found to effectively suppress cell proliferation and prolong the survival of mice with intracranial glioblastoma xenografts [47, 48].